Skip to main content
| News

Swiss TPH opens new building on the site of BaseLink

04.04.2022

The Swiss Tropical and Public Health Institute has officially opened its multifunctional new building at the Basel Area’s new life sciences hub. On the BaseLink site, up to 10,000 new jobs are being created.

New building "Belo Horizonte" of the Swiss Tropical and Public Health Institute. (img: Joachim Pelikan/Swiss TPH)

The Swiss Tropical and Public Health Institute (Swiss TPH) has combined its departments previously spread across seven buildings into a single new building at the BaseLink site in Allschwil. On April 1, the building, which was designed by Basel-based architects Kunz und Mösch and is known as Belo Horizonte, was officially opened. Across five floors, the new building offers space to house 725 modern workplaces and 150 laboratory places over an area of approximately 13,000 square meters. According to a press release, up to 10,000 new jobs are to be created at the site.

In her address, State Secretary Martina Hirayama praised the institute for making “an important contribution to improving the health of people in Switzerland and around the world” as well as for “driving innovation”. According to the information in the press release, the new building facilitates “attractive forms of interdisciplinary collaboration in order to tackle global challenges and solution approaches in a spirit of partnership”.

Close proximity to Switzerland Innovation Park Basel Area

Director of Swiss TPH, Jürg Utzinger, described the opening of the new building as an historic day for Swiss TPH: “Almost 80 years after our founding we can call this great building our new home”. As such, the “transformation from the so called ‘Tropeli’ to ‘Swiss TPH’ is complete and we can continue to advance our mission of making the world a healthier place”.

According to Nicole Nüssli-Kaiser, Mayor of Allschwil, the new Swiss TPH is an “important anchor institution” at the BaseLink site, where an emerging life sciences in Switzerland cluster is developing. This is situated in close proximity to the Switzerland Innovation Park Basel Area Main Campus, which is set to open in the fall of 2022. Other companies including Abbott, Basilea Pharmaceutica, Idorsia, Johnson&Johnson and Skan have established a presence in the vicinity as well.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.